EcoDrugPlus

Prostaglandin E Receptor 2

Ensembl ID : ENSMLUG00000027363
Gene Symbol: PTGER2
2 Cross references
241 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSMLUG00000001754
Gene Symbol: PTGER3
2 Cross references
194 Possible Orthologues:

Prostaglandin E Receptor 4

Ensembl ID : ENSMLUG00000010038
Gene Symbol: PTGER4
2 Cross references
274 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSMLUG00000008646
Gene Symbol: PTGFR
2 Cross references
195 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSMLUG00000004805
Gene Symbol: PTGS1
2 Cross references
256 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSMLUG00000008204
Gene Symbol: PTGS2
2 Cross references
237 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSMLUG00000009251
Gene Symbol: PSMA1
2 Cross references
250 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSMLUG00000007590
Gene Symbol: PSMA3
2 Cross references
235 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSMLUG00000027860
Gene Symbol: PSMA4
2 Cross references
250 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSMLUG00000008497
Gene Symbol: PSMA5
2 Cross references
210 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSMLUG00000010228
Gene Symbol: PSMA6
2 Cross references
297 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSMLUG00000000308
Gene Symbol: PSMA7
2 Cross references
155 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).